首页> 外文期刊>The journal of immunology >Inflammatory Responses Induced by Lipopolysaccharide Are Amplified in Primary Human Monocytes but Suppressed in Macrophages by Complement Protein C5a
【24h】

Inflammatory Responses Induced by Lipopolysaccharide Are Amplified in Primary Human Monocytes but Suppressed in Macrophages by Complement Protein C5a

机译:脂多糖诱导的炎症反应在原代人单核细胞中被放大,但在巨噬细胞中被补体蛋白C5a抑制。

获取原文
           

摘要

Monocytes and macrophages are important innate immune cells equipped with danger-sensing receptors, including complement and Toll-like receptors. Complement protein C5a, acting via C5aR, is shown in this study to differentially modulate LPS-induced inflammatory responses in primary human monocytes versus macrophages. Whereas C5a enhanced secretion of LPS-induced IL-6 and TNF from primary human monocytes, C5a inhibited these responses while increasing IL-10 secretion in donor-matched human monocyte-derived macrophages differentiated by GM-CSF or M-CSF. Gαi/c-Raf/MEK/ERK signaling induced by C5a was amplified in macrophages but not in monocytes by LPS. Accordingly, the Gαi inhibitor pertussis toxin and MEK inhibitor U0126 blocked C5a inhibition of LPS-induced IL-6 and TNF production from macrophages. This synergy was independent of IL-10, PI3K, p38, JNK, and the differentiating agent. Furthermore, C5a did not inhibit IL-6 production from macrophages induced by other TLR agonists that are selective for Toll/IL-1R domain–containing adapter inducing IFN-β (polyinosinic-polycytidylic acid) or MyD88 (imiquimod), demonstrating selectivity for C5a regulation of LPS responses. Finally, suppression of proinflammatory cytokines IL-6 and TNF in macrophages did not compromise antimicrobial activity; instead, C5a enhanced clearance of the Gram-negative bacterial pathogen Salmonella enterica serovar Typhimurium from macrophages. C5aR is thus a regulatory switch that modulates TLR4 signaling via the Gαi/c-Raf/MEK/ERK signaling axis in human macrophages but not monocytes. The differential effects of C5a are consistent with amplifying monocyte proinflammatory responses to systemic danger signals, but attenuating macrophage cytokine responses (without compromising microbicidal activity), thereby restraining inflammatory responses to localized infections.
机译:单核细胞和巨噬细胞是重要的先天免疫细胞,配备有危险感应受体,包括补体和Toll样受体。这项研究显示,补体蛋白C5a通过C5aR发挥作用,可在原代人单核细胞和巨噬细胞中差异调节LPS诱导的炎症反应。 C5a增强了原代人单核细胞分泌LPS诱导的IL-6和TNF的分泌,而C5a抑制了这些反应,同时增加了由GM-CSF或M-CSF分化的供体匹配的人单核细胞衍生的巨噬细胞的IL-10分泌。 C5a诱导的Gαi/ c-Raf / MEK / ERK信号在LPS中在巨噬细胞中扩增,但在单核细胞中未扩增。因此,Gαi抑制剂百日咳毒素和MEK抑制剂U0126阻断了C5a对巨噬细胞对LPS诱导的IL-6和TNF产生的抑制。这种协同作用独立于IL-10,PI3K,p38,JNK和分化剂。此外,C5a不会抑制由其他TLR激动剂诱导的巨噬细胞产生IL-6,这些TLR激动剂对包含Toll / IL-1R域的衔接子诱导IFN-β(多肌苷-聚胞苷酸)或MyD88(咪喹莫特)具有选择性,证明了对C5a的选择性LPS反应的调节。最后,巨噬细胞中促炎细胞因子IL-6和TNF的抑制不影响抗菌活性。相反,C5a增强了从巨噬细胞清除革兰氏阴性细菌病原体肠炎沙门氏菌血清鼠伤寒的能力。因此,C5aR是调节开关,其通过人巨噬细胞而非单核细胞中的Gαi/ c-Raf / MEK / ERK信号转导轴调节TLR4信号转导。 C5a的不同作用与放大对系统性危险信号的单核细胞促炎反应一致,但减弱了巨噬细胞细胞因子应答(不影响杀微生物活性),从而抑制了对局部感染的炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号